Keyphrases
Acute Respiratory Tract Infection
19%
Amphotericin B
23%
Antibiotics
21%
Bacteremia
20%
Bacterial Pneumonia
22%
Candida Glabrata
21%
Candidemia
19%
Chest CT
17%
Clarithromycin
24%
Clinical Characteristics
29%
Clinical Efficacy
27%
Combination Therapy
19%
Community-acquired Pneumonia
33%
COVID-19
70%
Cryptococcus Neoformans
28%
Daptomycin
21%
Fever
16%
Fluconazole
21%
Haemophilus Influenzae
26%
Hematogenous
17%
Hospitalized Patients
16%
In Vivo Efficacy
22%
Influenza Pneumonia
19%
Influenza Virus
19%
Japan
100%
Linezolid
58%
Lung
40%
Methicillin-resistant Staphylococcus Aureus
59%
Micafungin
18%
Murine Model
34%
Mycobacterium Tuberculosis (M. tb)
17%
Nagasaki
40%
Neoformans
20%
Neutralizing Antibodies
16%
Older Men
16%
Pharmacokinetics
20%
Pneumonia
35%
Pseudomonas Aeruginosa (P. aeruginosa)
31%
Pulmonary Cryptococcosis
43%
Pulmonary Infection
18%
Quantitative PCR
20%
Respiratory Infection
25%
Rifampicin
18%
Staphylococcus Aureus Bacteremia
18%
Streptococcus Pneumoniae
36%
Therapeutic Drug Monitoring
17%
Thrombocytopenia
26%
University Hospital
16%
Vancomycin
24%
Viral Load
17%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
12%
Amphotericin B
26%
Antibiotics
16%
Antifungal Agent
14%
Antiinfective Agent
26%
Aspergillus
14%
Aspergillus fumigatus
13%
Bacterial Pneumonia
21%
Bloodstream Infection
14%
Candida
11%
Clarithromycin
19%
Clinical Feature
13%
Cohort Study
15%
Combination Therapy
19%
Community Acquired Pneumonia
28%
Coronavirinae
16%
Daptomycin
20%
Disease
27%
Haemophilus influenzae
16%
Health Care Associated Pneumonia
13%
Hemodialysis
11%
Infection
74%
Invasive Aspergillosis
15%
Itraconazole
14%
Legionella
13%
Legionella pneumophila
14%
Levofloxacin
11%
Linezolid
58%
Lung Aspergillosis
15%
Lung Infection
15%
Meropenem
13%
Methicillin Resistant Staphylococcus Aureus Infection
31%
Methicillin-Resistant Staphylococcus Aureus
50%
Micafungin
15%
Mouse Model
11%
Mycosis
12%
Neutralizing Antibody
13%
Pharmacodynamics
15%
Pharmacokinetics
43%
Piperacillin
11%
Pseudomonas aeruginosa
25%
Pulmonary Cryptococcosis
11%
Quinolone Derivative
12%
Respiratory Tract Infection
34%
SARS Coronavirus
41%
Sivelestat
13%
Streptococcus
11%
Therapeutic Drug Monitoring
16%
Thrombocytopenia
26%
Vancomycin
20%
Medicine and Dentistry
Abscess
8%
Amphotericin B
13%
Antibiotics
14%
Antiinfective Agent
19%
Aspergillus
7%
Bacterial Pneumonia
12%
Blood Culture
10%
Bloodstream Infection
15%
Chemotherapy
16%
Chest Radiograph
8%
Clinical Feature
9%
Clinical Trial
10%
Cohort Study
9%
Community-Acquired Pneumonia
19%
Computer Assisted Tomography
14%
Coughing
10%
COVID-19
41%
Cystic Fibrosis
9%
Differential Diagnosis
7%
Disease
16%
Endocarditis
8%
Erysipelothrix rhusiopathiae
8%
Fulminant
7%
Haemophilus influenzae
9%
Health Care Associated Pneumonia
9%
Human Immunodeficiency Virus
8%
Infection
51%
Influenza Virus
8%
Invasive Aspergillosis
13%
Itraconazole
8%
Legionella pneumophila
9%
Lung
17%
Lung Aspergillosis
8%
Lung Transplantation
8%
Meropenem
9%
Methicillin Resistant Staphylococcus Aureus
13%
Micafungin
10%
Pathogen
19%
Penicillinase
10%
Piperacillin/Tazobactam
8%
Pneumococcal Infection
7%
Pneumococcus
22%
Pseudomonas aeruginosa
10%
Pulmonary Cryptococcosis
13%
Respiratory Failure
11%
Respiratory Tract Infection
23%
Reverse Transcription Polymerase Chain Reaction
9%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Silo-Filler's Disease
7%
Sputum
19%